Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating sirolimus for cerebral aneurysms, with recruitment ongoing at the University of Miami.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: University of Miami | Conditions: Cerebral Aneurysm | Phase 2 | Status: RECRUITING